Maintenance Treatment with Cetuximab and BAY86-9766 Increases Antitumor Efficacy of Irinotecan plus Cetuximab in Human Colorectal Cancer Xenograft Models

Abstract

The use of cetuximab in the treatment of metastatic colorectal cancer is limited by development of resistance

    Similar works